Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib helps improve hair growth in severe alopecia, with better results in less severe cases and higher doses working faster.

FAI is a better marker for predicting female hair loss than testosterone or SHBG alone.

IMA and IMA/albumin levels don't predict alopecia areata severity.

Sickle cell disease affects BMI and pain frequency, with HbSS patients having more pain and unhealthy BMI.

Baricitinib was effective in regrowing eyebrow and eyelash hair in patients with severe alopecia areata.

The Brigham Eyebrow Tool for Alopecia is a simple and reliable way to measure eyebrow hair loss.

B-mode ultrasonography and shear-wave elastography can help predict androgenetic alopecia early.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

The Free Androgen Index (FAI) is the best indicator of early hair loss in men before age 30.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

Endovascular repair and open surgery for abdominal aortic aneurysms both result in a temporary decline in physical health, with no significant mental health difference, and a return to near normal health in 90 days.

Popliteal Artery Entrapment Syndrome (PAES) is a rare but possible cause of leg pain during walking, even in untrained women.

The study helps doctors use patient images to understand and apply SALT scores for treating severe alopecia areata.

Higher NLR, PLR, and MPV may help diagnose androgenetic alopecia.

Higher apelin-12 levels may indicate more severe acne.

Capsaicin cream quickly relieved itching in two patients with brachioradial pruritus.

Stag parts were historically used in medicine for various health issues.

The InCISE score is a promising tool for assessing wound healing in head and neck surgery but needs more research for broader use.

Hair loss may indicate higher risk of heart disease.

Hair cortisol may help identify adrenal insufficiency in sickle cell disease patients.

Baricitinib helps grow eyebrows and eyelashes in severe alopecia areata patients.

The patient with Ankylosing Spondylitis had shoulder joint damage and bone changes.

The Breast Utility Instrument was developed to assess quality of life in breast cancer patients.

People with alopecia areata have higher levels of a heart disease marker in their blood.

Higher ischemia-modified albumin levels are linked to acne severity.

Higher variability in systolic blood pressure increases long-term mortality risk in coronary artery disease patients.

Serum IMA levels don't help diagnose AGA but may indicate its severity.

The Brazilian version of the Alopecia Areata Quality of Life Index is reliable for assessing patients' quality of life.